S3 Investment Company Inc. announced that representatives from the new Redwood Medical subsidiary are in the United States to meet with the manufacturers of the first product that Redwood Medical Inc. will distribute into the China market. Redwood Medical has an exclusive distribution agreement for the China market, which is seeing increased demand for the best available medical technologies for a growing number of hospital and clinics in the country. Two members of the Redwood Medical team have arrived in the U.S. and are meeting with the product developer and manufacturer this week. One of the areas of discussion will be the development of specific product characteristics that will make it more marketable in China, including results printed in Chinese languages.

S3 Investment Company Inc. announced the appointment of Karen Riessen as controller, replacing Lesly H. Mohr, who served in that position since April 2008. The primary area of responsibility for the controller is to ensure that the company meets the financial reporting necessary to maintain its 'current information' status with the Pink Sheets OTC Disclosure and News Service. Riessen brings considerable experience as controller for several venture funded start-up clients. This experience will be invaluable for S3 and its potential subsidiary clients. In her role, she has maintained monthly financial data, payroll and monthly and year-to-date financial statements.

S3 Investment Company Inc. announced the formation of Redwood Group International, which will expand the structure of S3's subsidiary businesses to allow the company to pursue additional opportunities in the China market. Redwood Group International is a company registered in Hong Kong and formed as a wholly owned subsidiary of S3 Investment Company. It, in turn, has two wholly owned operating subsidiaries, Redwood Capital Inc. and Redwood Medical Inc. Redwood Capital will continue to operate with its core focus of assisting private Chinese companies in accessing the North American capital markets by utilizing a network of investment banking relationships to achieve reverse merger (or reverse takeover) transactions. Redwood Medical has been established to serve companies seeking to import Western medical technologies and products into China, widely considered the largest consumer market in the world.